Cargando…
Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998308/ https://www.ncbi.nlm.nih.gov/pubmed/35986861 http://dx.doi.org/10.1007/s40620-022-01435-5 |
| _version_ | 1784903448785846272 |
|---|---|
| author | Gillion, Valentine Dahan, Karin Scohy, Anaïs Devresse, Arnaud Godefroid, Nathalie |
| author_facet | Gillion, Valentine Dahan, Karin Scohy, Anaïs Devresse, Arnaud Godefroid, Nathalie |
| author_sort | Gillion, Valentine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9998308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99983082023-03-11 Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? Gillion, Valentine Dahan, Karin Scohy, Anaïs Devresse, Arnaud Godefroid, Nathalie J Nephrol Lessons for the Clinical Nephrologist Springer International Publishing 2022-08-20 2023 /pmc/articles/PMC9998308/ /pubmed/35986861 http://dx.doi.org/10.1007/s40620-022-01435-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Lessons for the Clinical Nephrologist Gillion, Valentine Dahan, Karin Scohy, Anaïs Devresse, Arnaud Godefroid, Nathalie Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| title | Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| title_full | Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| title_fullStr | Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| title_full_unstemmed | Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| title_short | Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| title_sort | lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? |
| topic | Lessons for the Clinical Nephrologist |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998308/ https://www.ncbi.nlm.nih.gov/pubmed/35986861 http://dx.doi.org/10.1007/s40620-022-01435-5 |
| work_keys_str_mv | AT gillionvalentine lessonsfortheclinicalnephrologistlumasiranasthefuturecornerstonetreatmentforpatientswithprimaryhyperoxaluriatype1 AT dahankarin lessonsfortheclinicalnephrologistlumasiranasthefuturecornerstonetreatmentforpatientswithprimaryhyperoxaluriatype1 AT scohyanais lessonsfortheclinicalnephrologistlumasiranasthefuturecornerstonetreatmentforpatientswithprimaryhyperoxaluriatype1 AT devressearnaud lessonsfortheclinicalnephrologistlumasiranasthefuturecornerstonetreatmentforpatientswithprimaryhyperoxaluriatype1 AT godefroidnathalie lessonsfortheclinicalnephrologistlumasiranasthefuturecornerstonetreatmentforpatientswithprimaryhyperoxaluriatype1 |